,,ii  #aahth ,,congress  #ast ,session  
,s4 #bhhf  ,,in ,,the ,,senate ,,of     
,,the ,,united ,,states  ,september #ba1
 #bjbc,mr4 ,van ,hollen 7for himself1   
,mr4 ,brown1 ,mr4 ,blumenthal1 and ,mr4 
,coons7 introduced the following bill2  
which was read twice and referred to the
 ,committee on ,health1 ,education1     
,labor1 and ,pensions  ,a ,,bill  ,to   
permit manufacturers of generic drugs to
 provide additional warnings with       
respect to such drugs in the same manner
 that the ,food and ,drug               
,administration allows brand names to do
 so4  #a4 ,short title ,this ,act may be
 cited as the ,updated ,drug ,labeling  
for ,patient ,safety ,act4  #b4 ,warning
 labeling with respect to generic drugs 
,section #eje7;j7 of the ,federal ,food1
 ,drug1 and ,cosmetic ,act 7#ba         
,u4,s4,c4 #cee7;j77 is amended by adding
 at the end the following3  7#ad7 7,a7  
,notwithstanding any other provision of 
this ,act1 the holder of an approved    
application under this subsection may   

change the labeling of a drug so        
approved in the same manner authorized  
by regulation for the holder of an      
approved new drug application under     
subsection 7b74  7,b7 ,in the event of a
 labeling change made under subparagraph
 7,a71 the ,secretary may order         
conforming changes to the labeling of   
the equivalent listed drug and each drug
 approved under this subsection that    
corresponds to such listed drug4  4